Contineum Therapeutics
CTNM
#7668
Rank
A$0.55 B
Marketcap
A$19.01
Share price
1.04%
Change (1 day)
-15.59%
Change (1 year)

Earnings for Contineum Therapeutics (CTNM)

Earnings in 2025 (TTM): -A$92.77 Million

According to Contineum Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$63.62 Million a decrease over its 2023 earnings that were of A$34.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Contineum Therapeutics from 2023 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$92.77 Million45.84%
2024 -A$63.62 Million-282.38%
2023 A$34.87 M